Related Experiment Video
Updated: Oct 21, 2025

08:32
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
3.8K
R4 RGS proteins suppress engraftment of human hematopoietic stem/progenitor cells by modulating SDF-1/CXCR4 signaling
Kathy Yuen Yee Chan1, Chi Zhang1, Yorky Tsin Sik Wong1
1Department of Paediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong.
Blood Advances
|September 9, 2021
Summary
Regulators of G-protein signaling (RGS) proteins RGS1, RGS13, and RGS16 inhibit hematopoietic stem cell (HSC) homing and bone marrow engraftment. Targeting these RGS proteins may improve stem cell transplantation outcomes.
Area of Science:
- Hematology
- Molecular Biology
- Immunology
Background:
- Hematopoietic stem/progenitor cell (HSPC) homing and engraftment are regulated by stromal cell-derived factor-1 (SDF-1) and C-X-C motif chemokine receptor 4 (CXCR4).
- Regulators of G-protein signaling (RGS) proteins, particularly R4 subfamily members, influence mature hematopoietic cell trafficking but their role in HSPCs is unclear.
Purpose of the Study:
- To investigate the expression and function of R4 RGS proteins in human HSPCs.
- To determine the impact of RGS proteins on SDF-1/CXCR4-mediated signaling and HSPC engraftment.
- To elucidate the molecular mechanisms by which RGS proteins regulate stem cell function.
Main Methods:
- Analysis of RGS gene expression in human CD34+ cells.
- Overexpression of RGS1, RGS13, and RGS16 in CD34+ cells.
- In vitro migration and calcium mobilization assays.
- In vivo engraftment studies in NOD/SCID mice.
- Genome-wide microarray analysis.
- Network modeling of signaling pathways.
Main Results:
- Human CD34+ cells express multiple R4 RGS genes, upregulated by SDF-1 via CXCR4.
- Overexpression of RGS1, RGS13, or RGS16 inhibited SDF-1-induced migration, calcium flux, and key signaling pathways (AKT, ERK, STAT3).
- RGS overexpression markedly reduced HSPC engraftment in vivo and was associated with downregulation of stem cell trafficking/maintenance effectors.
- Gain-of-function of effectors or ex vivo priming enhanced HSPC engraftment.
Conclusions:
- Specific R4 RGS proteins (RGS1, RGS13, RGS16) act as critical negative regulators of HSPC homing and bone marrow engraftment.
- These RGS proteins impair SDF-1/CXCR4 signaling, affecting kinase activity and stem cell functions.
- Targeting RGS proteins offers a potential strategy to enhance clinical HSPC transplantation efficacy.

